Introduction
============

Atherosclerosis is a complex disease with both environmental and genetic susceptibility components. The heritability of atherosclerotic coronary artery disease (CAD) in humans is evident from family history being a significant risk factor.^[@b1]--[@b2]^ In addition, genome‐wide association studies (GWAS) have identified multiple loci associated with CAD.^[@b3]^ However, these studies have a tremendous statistical burden to overcome to meet the threshold of genome‐wide significance, and thus much of the genetic contribution may underreported. Also, GWAS do not ascertain rare variants, and it is becoming increasingly clear that rare variants in aggregate can account for a significant portion of population variance for complex traits such as plasma triglycerides.^[@b4]^ Thus, there is still impetus to identify novel genes and pathways that play a role in atherosclerosis susceptibility. Genetics also plays a role in lesion development in mouse models of atherosclerosis, as different inbred strains have markedly different aortic lesion areas.^[@b5]^ Mouse models provide an opportunity to tease out the potential genetic modifiers for multigenic phenotypes. We have previously shown that AKR apoE^−/−^ mice have ≈10‐fold smaller aortic root lesions compared with DBA/2 apoE^−/−^ mice when fed a chow diet.^[@b5]^ A previous intercross between these 2 strains identified 2 significant and 4 suggestive quantitative trait loci (QTLs) for aortic root lesion area. Just as lesion area is a quantitative trait that can be used for gene mapping studies, gene expression levels can likewise be treated as a quantitative trait to map the expression QTLs (eQTLs), or the loci that control the expression of specific transcripts.^[@b6]^ We had previously performed an eQTL analysis using macrophages from the F2 cohort of the AKR apoE^−/−^×DBA/2 apoE^−/−^ strain intercross.^[@b7]^ Here, we report atherosclerosis (Ath) QTL and eQTL findings from a second independent strain intercross of these same 2 strains.

We found that both significant Ath QTLs in the prior cross were replicated in the new cross, whereas only one of the prior suggestive Ath QTLs was replicated. We carefully excluded analysis of transcriptome data from microarray probes that contained strain‐specific sequence polymorphisms, and we still found robust replication of macrophage *cis*‐acting eQTLs between the prior and new crosses. We also observed many *cis*‐eQTLs that were conserved between macrophages and endothelial cells (ECs). However, *trans*‐acting eQTLs were not well replicated between the 2 crosses, leading us to believe that there is a high false‐positive rate for the identification of *trans*‐eQTLs. We compiled the lists of all protein coding differences between the AKR and DBA/2 strains, as well as the eQTLs, within the replicated Ath QTLs. These genes provide a comprehensive list of candidates that may be responsible for the observed Ath QTLs.

Methods
=======

Mouse and Cell Studies
----------------------

A DBA/2J apoE^−/−^×AKR/J apoE^−/−^ reciprocal strain intercross was performed to generate an F~1~ cohort and the subsequent F~2~ cohort of 89 males and 77 females. The F~2~ mice were weaned at 21 days and placed on a chow diet. Mice were killed at 16 weeks of age. Femurs were collected from all mice, and the descending aortas were removed from males for culture of ECs as described later. Tail‐tip DNA was prepared from each F~2~ mouse by proteinase K digestion followed by ethanol precipitation. Lesion areas of the aortic root were quantified as previously described.^[@b8]^ Genotyping was performed using Illumina Golden Gate mouse genotyping arrays. Genotyping calls were made using Illumina Genome Studio software. In all, 599 informative markers between AKR and DBA/2 were used for QTL and eQTL analyses.

Bone marrow‐derived macrophages (BMMs) were derived as previously described.^[@b7]^ To obtain cultured ECs from the F2 mice, descending aortas were isolated, cut into 2‐mm sections, placed on top of matrigel‐coated plates, and grown to confluence (≈10 to 14 days) in DMEM supplemented as previously described.^[@b9]^ Cells were treated with dispase and passaged twice before RNA isolation. This protocol was successful in obtaining EC cultures in 48 of 89 attempts. RNA was isolated using Qiagen\'s total RNA kits and digested with DNase I for 12 minutes at room temperature to remove genomic DNA. RNA integrity was confirmed by agarose gel electrophoresis. cDNA was synthesized using Illumina protocols and reagents and hybridized on Illumina Mouse Ref‐8 v2 microarrays. All expression, phenotype, and genotype data are available in GEO (accession No. GSE35676).

Statistical Methods
-------------------

Ath QTLs, using the log10 of aortic root lesion areas, were mapped using the R package qtl (R/qtl).^[@b10]^ False discovery rates (FDRs) were estimated with 100 000 permutations using the scanone function in R/qtl. The Ath QTL CIs were calculated within the same software using the Bayesian credible interval function.

Gene expression data were loaded into the R‐package *lumi*^[@b11]^ log2 transformed and quantile normalized. eQTLs were mapped using the scanone function in the R/qtl.^[@b10]^ Probes were mapped using BLAT^[@b12]^ against the mouse mm9 reference genome. Probes that matched to multiple locations or annotated transcripts from Ensembl release 63 were discarded. Probes containing polymorphisms, either an indel or a single nucleotide polymorphism (SNP), or probes mapping to known structural variants between DBA/2 and AKR strains^[@b13]--[@b14]^ were discarded because they could lead to identification of false *cis*‐eQTLs.^[@b15]^ This was performed by taking the genomic locations from BLAT in the University of California Santa Cruz Genome Browser and using Tabix^[@b16]^ to retrieve sequence variants from the Mouse Genome Sequencing Project.^[@b13]--[@b14]^ This filtering resulted in the removal of 2749 probes from the data set.

Human--mouse alignments generated previously by Schwarz et al^[@b17]^ were used to obtain the human regions corresponding to our mouse Ath QTLs, and within these regions we identified human GWAS loci^[@b18]^ related to CAD.

To compare eQTLs from the current and previous studies,^[@b7]^ matches between Affymetrix and Illumina\'s probes were provided by Illumina (<http://www.switchtoi.com/probemapping.ilmn>). To perform the combined cross‐QTL analyses, the SNPs from each cross were imput to each other using the fill.geno function in R/qtl, with the simple assumption of no double crossovers. In the prior cross, there were 1947 markers, whereas in the new cross, there were 599 markers, of which only 170 overlapped between the 2, leading to 2376 total markers. There is no metric for imputation quality, but we found that using the original set of markers in the second cross versus the combined set of markers did not greatly alter QTL location or strength. A liberal 20‐Mb window was used between studies to determine if an eQTL overlapped. A combined eQTL analysis was done with data from both studies, using cross membership as an additive covariate and sex as an interactive covariate.

Results and Discussion
======================

Atherosclerosis QTL Replication in a New Cross
----------------------------------------------

F~2~ mice were generated using a reciprocal cross strategy from apoE^−/−^ mice on the AKR and DBA/2 backgrounds. Lesion areas in the aortic root were quantified in 166 F~2~ mice (77 female and 89 male). A genome scan was performed for each F~2~ mouse using 599 informative SNPs. We defined significant QTLs as those that have genome‐wide FDRs of \<10%, by permutation analysis. Combining both sexes and using sex as an interactive covariate, we identified 3 suggestive Ath QTLs at a logarithm of odds (LOD) score threshold of 2.0 on chromosomes 2, 15, and 17 with FDRs of 15%, 30%, and 16%, respectively ([Table 1](#tbl01){ref-type="table"}). Although these Ath QTLs only met the suggestive threshold due to small sample size, each of these Ath QTLs were detected in a prior AKR×DBA/2 strain intercross^[@b19]^: *Ath28,* a suggestive QTL on chromosome 2; *Ath22,* a significant QTL on chromosome 15; and *Ath26,* a significant QTL on chromosome 17. We performed a combined Ath QTL analysis using both crosses with cohort membership as an additive covariate and sex as an interactive covariate. As the platform and markers used to genotype the 2 crosses differed, R/qtl^[@b20]^ was used to impute the genotypes between the 2 crosses. On chromosome 2, *Ath28* was replicated and had a combined LOD score of 5.9; on chromosome 15, *Ath22* was replicated with a combined LOD score of 5.3; and on chromosome 17, *Ath26* was replicated with a combined LOD score of 5.6 ([Figure 1](#fig01){ref-type="fig"}). All of these combined LOD scores met the genome‐wide FDR threshold of \<10%, and in fact they all had \<5% FDR. However, the suggestive Ath QTLs identified in the first cross using sex as an interactive covariate on chromosomes 5, 3, and 13^[@b19]^ were not replicated in the second cross. The approximate 95% Bayesian credible interval was obtained for all 3 loci ([Table 1](#tbl01){ref-type="table"}). Thus, the clinical trait mouse QTL model is partially reproducible for a phenotype as complex as lesion area, which has a fairly large coefficient of variation within inbred strains.

###### 

Aortic Root Lesion (log10) QTLs in DBA/2×AKR F2 Cohort

  Symbol    Chromosome   Bayesian CI,[\*](#tf1-1){ref-type="table-fn"} Mb   Second Cross LOD Score   Prior Cross LOD Score   FDR    Combined Cross LOD   FDR
  --------- ------------ -------------------------------------------------- ------------------------ ----------------------- ------ -------------------- --------
  *Ath28*   2            165.1 to 179.3                                     2.8                      3.2                     0.15   5.9                  \<0.05
  *Ath22*   15           3.6 to 31.9                                        2.0                      2.1                     0.30   5.3                  \<0.05
  *Ath26*   17           12.4 to 64.3                                       2.7                      4.4                     0.16   5.6                  \<0.05

QTL indicates quantitative trait loci; LOD, logarithm of odds; FDR, false discovery rate.

Based on the combined cross‐analysis.

![Log10 aortic root lesion atherosclerosis (Ath) quantitative trait locus (QTL) plots. The pink and blue lines show the logarithm of odds (LOD) plots for the prior and new crosses of AKR apoE^−/−^ and DBA/2 apoE^−/−^ mice, respectively. The black line shows the LOD plot for the combined analysis using cross as an additive covariate. In all analyses, sex was used as an interactive covariate.](jah3-2-e005421-g1){#fig01}

We identified the human chromosome segments orthologous to these mouse loci. We examined whether these human orthologous regions contained common genetic variants associated with CAD, myocardial infarction, or related risk factors by searching the National Human Genome Research Institute GWAS catalog^[@b18]^ ([Table 2](#tbl02){ref-type="table"}). The known atherosclerosis‐related risk factors included blood lipid levels, subclinical atherosclerosis, type 2 diabetes, and hypertension. There were no human CAD GWAS hits in the region in synteny with *Ath28*, although ≈21% of the *Ath28* interval on chromosome 2 displayed no synteny due to complex expansion in the mouse genome after species divergence. The *Ath22* locus on chromosome 15 contains the corresponding segment on human chromosome 5 that has been associated with subclinical atherosclerosis.^[@b21]^ The *Ath26* locus on chromosome 17 corresponds to human chromosomes 6 (primarily) and 19, including the major histocompatibility complex locus, and overlaps with multiple human GWAS loci for CAD and related risk factors ([Table 2](#tbl02){ref-type="table"}).

###### 

Corresponding GWAS Hits in Human Orthologous Regions

  Chromosome     Position    rsID         Author            Trait                                          Nearest Gene
  -------------- ----------- ------------ ----------------- ---------------------------------------------- ---------------------
  2 (*Ath28)*                                                                                              
  No hits                                                                                                  
  15 (*Ath22*)                                                                                             
  5              13764419    rs2896103    C.J. O\'Donnell   Subclinical atherosclerosis traits (other)     *DNAH5*
  5              13769974    rs7715811    C.J. O\'Donnell   Subclinical atherosclerosis traits (other)     *DNAH5*
  5              13779743    rs1502050    C.J. O\'Donnell   Subclinical atherosclerosis traits (other)     *DNAH5*
  17 (*Ath26*)                                                                                             
  6              160578859   rs1564348    T.M. Teslovich    LDL cholesterol                                *LPA*
  6              160578859   rs1564348    T.M. Teslovich    Cholesterol, total                             *LPA*
  6              160741621   rs3120139    Q. Qi             Lp(a) levels                                   *SLC22A3*
  6              160863531   rs2048327    D.A. Tregouet     Coronary heart disease                         *SLC22A3,LPAL2,LPA*
  6              160863531   rs2048327    D.A. Tregouet     Coronary heart disease                         *SLC22A3,LPAL2,LPA*
  6              160907133   rs3127599    D.A. Tregouet     Coronary heart disease                         *SLC22A3,LPAL2,LPA*
  6              160907133   rs3127599    D.A. Tregouet     Coronary heart disease                         *SLC22A3,LPAL2,LPA*
  6              160910516   rs12214416   Q. Qi             Lp(a) levels                                   *LPAL2*
  6              160960358   rs6919346    C. Ober           Lp(a) levels                                   *LPA*
  6              160961136   rs3798220    H. Schunkert      Coronary heart disease                         *LPA*
  6              160962502   rs7767084    D.A. Tregouet     Coronary heart disease                         *SLC22A3,LPAL2,LPA*
  6              160962502   rs7767084    D.A. Tregouet     Coronary heart disease                         *SLC22A3,LPAL2,LPA*
  6              160969737   rs10755578   D.A. Tregouet     Coronary heart disease                         *SLC22A3,LPAL2,LPA*
  6              160969737   rs10755578   D.A. Tregouet     Coronary heart disease                         *SLC22A3,LPAL2,LPA*
  6              161010117   rs10455872   D.I. Chasman      Response to statin therapy (LDL cholesterol)   *LPA*
  6              161010117   rs10455872   Q. Qi             Lp(a) levels                                   *LPA*
  6              161089816   rs1084651    T.M. Teslovich    HDL cholesterol                                *LPA*
  6              161137989   rs783147     Q. Qi             Lp(a) levels                                   *PLG*
  6              34546560    rs2814982    T.M. Teslovich    Cholesterol, total                             *C6orf106*
  6              34552797    rs2814944    T.M. Teslovich    HDL cholesterol                                *C6orf106*
  6              35034800    rs17609940   H. Schunkert      Coronary heart disease                         *ANKS1A*
  19             8433196     rs7255436    T.M. Teslovich    HDL cholesterol                                *ANGPTL4*
  19             8469738     rs2967605    S. Kathiresan     HDL cholesterol                                *ANGPTL4*
  6              31184196    rs3869109    R.W. Davies       Coronary heart disease                         *HCG27, HLA*‐*C*
  6              32412435    rs3177928    T.M. Teslovich    LDL cholesterol                                *HLA*
  6              32412435    rs3177928    T.M. Teslovich    Cholesterol, total                             *HLA*
  6              32669373    rs11752643   F. Takeuchi       Coronary heart disease                         *HLA, DRB*‐*DQB*
  6              33143948    rs2254287    C.J. Willer       LDL cholesterol                                *B3GALT4*
  6              43758873    rs6905288    R.W. Davies       Coronary heart disease                         *VEGFA*

GWAS indicates genome wide association studies; Lp(a), lipoprotein(a); LDL, low‐density lipoprotein; HDL, high‐density lipoprotein.

Protein Coding Differences Between AKR and DBA/2 Mice Residing in Ath QTLs
--------------------------------------------------------------------------

We used a variety of bioinformatic and genomic methods to identify candidate genes that may be responsible for the 3 replicated Ath QTLs. Using the mouse sequence data from 15 common inbred strains,^[@b13]--[@b14]^ we identified all of the nonsynonymous protein changes in these 3 loci. These strain variable genes on chromosomes 2 (11 genes), 15 (23 genes), and 17 (258 genes) are listed in Table S1, with many genes having \>1 amino acid substitution between these 2 strains. We identified many more strain variant genes for *Ath26* on chromosome 17, because it is a very large 52‐Mb gene‐dense interval that contains the highly polymorphic mouse H2 major histocompatibility region. After exclusion of the major histocompatibility genes, we used Polyphen 2^[@b22]^ to ascertain in silico the likelihood that each protein coding change would impair protein function, and we found numerous potential protein functional differences between the 2 strains (Tables [3](#tbl03){ref-type="table"} and S1).

###### 

AKR and DBA/2 Protein Differences Within the *Ath28*,*Ath22*, and *Ath26* CIs Predicted by Polyphen to Be Detrimental

  Chromosome   Position    Reference Allele   Alternate Allele   AKR[\*](#tf3-1){ref-type="table-fn"}   DBA[\*](#tf3-1){ref-type="table-fn"}   Gene Symbol   AA Position   AA Alteration   Polyphen Score[\*](#tf3-2){ref-type="table-fn"}
  ------------ ----------- ------------------ ------------------ -------------------------------------- -------------------------------------- ------------- ------------- --------------- -------------------------------------------------
  2            165177862   C                  T                  1/1                                    0/0                                    *Zfp663*      646           G\>R            0.98
  2            165179205   G                  A                  1/1                                    0/0                                    *Zfp663*      198           T\>I            0.969
  2            172377285   T                  C                  0/0                                    1/1                                    *Tcfap2c*     143           Y\>H            0.917
  2            173034738   G                  C                  1/1                                    0/0                                    *Zbp1*        280           T\>S            0.944
  15           3929418     C                  T                  0/0                                    1/1                                    *Fbxo4*       3             G\>R            1
  15           4705267     G                  A                  1/1                                    0/0                                    *C6*          205           R\>K            1
  15           4741106     G                  T                  1/1                                    0/0                                    *C6*          533           R\>M            0.591
  15           4888423     G                  T                  1/1                                    0/0                                    *Heatr7b2*    981           Q\>H            0.989
  15           4984193     G                  A                  1/1                                    0/0                                    *C7*          242           T\>M            0.78
  15           9297067     T                  G                  1/1                                    0/0                                    *Ugt3a2*      380           H\>Q            0.966
  15           11834935    C                  T                  1/1                                    0/0                                    *Npr3*        154           A\>T            1
  15           27492564    C                  T                  0/0                                    1/1                                    *Ank*         201           A\>V            0.932
  15           28275570    C                  T                  0/0                                    1/1                                    *Dnahc5*      2434          R\>W            0.908
  17           12243519    G                  C                  0/0                                    1/1                                    *Park2*       397           E\>Q            1
  17           17987504    C                  T                  0/0                                    1/1                                    *Has1*        40            A\>T            0.638
  17           18048331    T                  G                  1/1                                    0/0                                    *Gm7535*      194           D\>A            0.958
  17           18048648    C                  T                  1/1                                    0/0                                    *Gm7535*      88            M\>I            0.875
  17           18395099    A                  G                  1/1                                    0/0                                    *Vmn2r94*     117           S\>P            1
  17           18719527    C                  T                  0/0                                    1/1                                    *Vmn2r96*     53            A\>V            1
  17           19084957    G                  T                  1/1                                    0/0                                    *Vmn2r97*     836           L\>F            0.951
  17           19203418    G                  T                  0/0                                    1/1                                    *Vmn2r98*     405           A\>S            0.937
  17           19204356    G                  A                  0/0                                    1/1                                    *Vmn2r98*     496           E\>K            0.979
  17           19814743    C                  G                  1/1                                    0/0                                    *Vmn2r102*    352           P\>R            0.806
  17           19910406    G                  C                  1/1                                    0/0                                    *Vmn2r103*    27            C\>S            1
  17           19949143    G                  T                  0/0                                    1/1                                    *Vmn2r103*    738           K\>N            1
  17           20405284    C                  T                  0/0                                    1/1                                    *Vmn2r106*    606           V\>I            0.986
  17           20415678    A                  C                  0/0                                    1/1                                    *Vmn2r106*    312           Y\>D            0.975
  17           20608324    C                  T                  1/1                                    0/0                                    *Vmn2r108*    300           M\>I            0.793
  17           20639402    T                  G                  1/1                                    0/0                                    *Vmn1r225*    47            L\>R            0.998
  17           21050607    A                  T                  0/0                                    1/1                                    *Vmn1r232*    232           F\>I            0.774
  17           21423632    C                  T                  0/0                                    1/1                                    *Vmn1r236*    16            T\>I            0.953
  17           23496190    G                  A,T                0/0                                    1/1                                    *Vmn2r115*    557           V\>F            0.892
  17           23802717    A                  T                  0/0                                    1/1                                    *Ccdc64b*     170           T\>S            0.961
  17           24558772    G                  A                  1/1                                    0/0                                    *Rnps1*       165           G\>E            0.953
  17           24701163    A                  G                  1/1                                    0/0                                    *Pkd1*        95            E\>G            0.985
  17           25240572    C                  T                  1/1                                    0/0                                    *Telo2*       664           V\>M            0.946
  17           25242093    C                  T                  0/0                                    1/1                                    *Telo2*       531           R\>H            1
  17           25247204    G                  A                  0/0                                    1/1                                    *Telo2*       301           R\>C            0.998
  17           25305356    A                  T                  0/0                                    1/1                                    *Ccdc154*     380           Q\>L            0.924
  17           25305357    G                  T                  0/0                                    1/1                                    *Ccdc154*     380           Q\>H            0.996
  17           25436769    T                  C                  0/0                                    1/1                                    *Prss34*      260           L\>P            0.996
  17           25457599    A                  G                  1/1                                    0/0                                    *Prss29*      74            T\>A            0.997
  17           29018352    G                  A                  1/1                                    0/0                                    *Pnpla1*      416           S\>N            0.766
  17           29018363    T                  A                  1/1                                    0/0                                    *Pnpla1*      420           L\>M            0.94
  17           29275100    G                  T                  1/1                                    0/0                                    *Rab44*       86            Q\>H            1
  17           29296944    C                  T                  1/1                                    0/0                                    *Cpne5*       506           V\>M            0.862
  17           29994582    C                  T                  1/1                                    0/0                                    *Mdga1*       54            D\>N            0.997
  17           30814214    C                  A,T                0/0                                    1/1                                    *Dnahc8*      886           L\>M            1
  17           31145549    A                  T                  0/0                                    1/1                                    *Umodl1*      1304          I\>F            0.933
  17           31372493    G                  A                  1/1                                    0/0                                    *Ubash3a*     450           V\>M            0.948
  17           32838830    C                  T                  1/1                                    0/0                                    *Cyp4f15*     378           S\>F            0.827
  17           33062306    A                  G                  1/1                                    0/0                                    *Cyp4f13*     453           S\>P            0.739
  17           33731241    C                  T                  1/1                                    0/0                                    *Myo1f*       658           R\>C            0.993
  17           34048493    A                  G                  1/1                                    0/0                                    *Daxx*        179           N\>S            0.734
  17           34057211    C                  G                  0/0                                    1/1                                    *Tapbp*       79            L\>V            0.669
  17           34069629    C                  T                  0/0                                    1/1                                    *Rgl2*        234           A\>V            0.999
  17           34072961    G                  A                  0/0                                    1/1                                    *Rgl2*        665           V\>I            0.969
  17           34102686    A                  T                  0/0                                    1/1                                    *Vps52*       663           S\>C            0.996
  17           34165995    C                  T                  1/1                                    0/0                                    *Slc39a7*     393           V\>M            0.968
  17           34195857    G                  A                  1/1                                    0/0                                    *Col11a2*     1044          A\>T            0.961
  17           34196094    G                  A                  0/0                                    1/1                                    *Col11a2*     1079          V\>M            0.996
  17           34499618    G                  A                  0/0                                    1/1                                    *Btnl2*       242           E\>K            0.904
  17           34518474    A                  C                  0/0                                    1/1                                    *Btnl3*       300           K\>Q            0.81
  17           34597021    A                  C                  1/1                                    0/0                                    *BC051142*    264           Q\>P            0.663
  17           34645055    G                  A,T                2/2                                    0/0                                    *Btnl6*       482           A\>D            0.996
  17           34645142    C                  G                  0/0                                    1/1                                    *Btnl6*       453           S\>T            0.936
  17           34645839    T                  C                  0/0                                    1/1                                    *Btnl6*       337           Q\>R            0.752
  17           34652479    C                  G                  0/0                                    1/1                                    *Btnl6*       85            E\>Q            0.893
  17           34670298    A                  G                  1/1                                    0/0                                    *Btnl7*       426           F\>L            0.999
  17           34670922    G                  A                  1/1                                    0/0                                    *Btnl7*       334           R\>C            0.999
  17           34679441    C                  T                  1/1                                    0/0                                    *Btnl7*       132           G\>R            0.997
  17           34721459    G                  A                  0/0                                    1/1                                    *Notch4*      1469          R\>Q            0.997
  17           34724653    A                  G                  1/1                                    0/0                                    *Notch4*      1873          Y\>C            0.995
  17           34735125    G                  A                  1/1                                    0/0                                    *Ager*        31            G\>E            1
  17           34782359    C                  T                  0/0                                    1/1                                    *Fkbpl*       52            P\>L            0.957
  17           34787670    G                  T                  0/0                                    1/1                                    *Atf6b*       233           A\>S            0.975
  17           34808447    A                  G                  0/0                                    1/1                                    *Tnxb*        273           Q\>R            0.963
  17           34831297    A                  C                  1/1                                    0/0                                    *Tnxb*        1903          E\>A            0.944
  17           34832575    C                  G                  1/1                                    0/0                                    *Tnxb*        2020          H\>D            0.794
  17           34833521    C                  T                  0/0                                    1/1                                    *Tnxb*        2167          T\>I            0.993
  17           34840315    C                  T                  0/0                                    1/1                                    *Tnxb*        2494          P\>S            0.992
  17           34867829    C                  T                  0/0                                    1/1                                    *C4b*         1442          R\>K            0.613
  17           35163365    G                  A                  0/0                                    1/1                                    *Ng23*        129           T\>M            0.941

AA indicates amino acid; MHC, major histocompatibility complex. Table excludes the MHC genes and several zinc‐finger protein genes.

0 is the reference allele; 1 is the first or only alternate allele; and 2 is the second alternate allele.

Probability of detrimental amino acid substitution, using \>0.5 as the threshold.

On chromosome 2, only 3 protein changes were predicted to be damaging in 1 strain relative to the other strain. *Zbp1* is a Z‐DNA binding protein, *Tcfap2c* is an AP‐2 transcription factor involved in early development, and Zfp663 is a zinc‐finger protein; none of these proteins have been previously implicated in atherosclerosis susceptibility. On chromosome 15, there were several protein coding changes that are predicted to be detrimental in 1 strain versus the other. Two components of the complement system, *C6* and *C7,* have predicted functional differences, both with the AKR version being detrimental. The complement system has potential roles in cardiovascular disease as previously reviewed.^[@b23]^ On chromosome 17, there were 50 genes with predicted detrimental changes, and many additional changes in major histocompatibility complex genes, that were not subjected to the Polyphen analysis. Some notable protein changes were found in *Rab44*,*Collagen 11a2*, and *Notch4*, which can alter cellular vesicular trafficking, extracellular matrix, and signal transduction, respectively, all potential atherosclerosis modifiers.

eQTLs in Bone Marrow--Derived Macrophages and Endothelial Cells
---------------------------------------------------------------

The global profile of gene expression in bone marrow--derived macrophages was assayed using Illumina microarrays from 79 female and 81 male F~2~ mice. With the same 599 SNPs used to map the Ath QTLs, we mapped eQTLs, or loci that are associated with the expression of each transcript, using sex as an additive covariate. An eQTL was defined as a *cis*‐eQTL if the eQTL mapped within 20 Mb of the probe position. A *trans*‐eQTL is defined as the QTL mapping anywhere else on the genome. To eliminate spurious eQTLs, we filtered out 2479 expression array probes that contained an SNP or insertion/deletion between these 2 strains, which could lead to altered probe hybridization impairing an accurate measure of gene expression. We validated that these strain variant probes would indeed lead to false *cis*‐eQTLs with on average an LOD score that was double the LOD score of comparable probes containing no variant (LOD 14.7 versus 7.6, *P*\<2.2×10^−6^). In addition, the transcripts with the nonreference SNP allele overlapping the probes were overwhelmingly called with lower expression values versus the transcripts containing the reference allele (Figure S1). After filtering out probes that were not expressed above background in ≥25% of the samples, 9600 probes were evaluated for eQTLs. We used a stringent FDR cut‐off of 5% to identify *cis*‐eQTLs, which corresponded to an LOD score threshold of 2.4 and found 937 *cis*‐eQTLs (Table S2). [Table 4](#tbl04){ref-type="table"} shows the top 25 *cis*‐eQTLs ranked by LOD score. Because *trans*‐eQTLs are indirect, and often not as strong as *cis*‐eQTLs, we applied both a liberal FDR cutoff of 30% and a stringent 5% cutoff. The 30% and 5% FDR thresholds corresponded to LOD scores of 2.81 and 3.75, respectively, with 3797 and 551 *trans*‐eQTLs identified, respectively (Table S3). [Table 5](#tbl05){ref-type="table"} shows the top 25 *trans*‐eQTLs ranked by LOD score.

###### 

Top 25 *cis*‐eQTLs by LOD Score in BMMs

  Gene Symbol       QTL Marker       QTL Chromosome   QTL Marker Position   LOD
  ----------------- ---------------- ---------------- --------------------- ------
  *Rnps1*           rs3719497        17               24100880              55.9
  *Fblim1*          rs3688566        4                140026440             54.0
  *Zfp277*          rs13481408       12               35475720              44.7
  *2210012G02Rik*   rs3709486        4                109968331             43.9
  *Atg9b*           CEL‐5_24211033   5                24211033              42.5
  *Vill*            rs3669563        9                117891342             41.2
  *Gjb4*            gnf04.123.367    4                126400415             35.3
  *Gm962*           CEL‐19_5283144   19               5283144               35.0
  *Insl6*           rs3090325        19               26007713              33.3
  *Gm962*           CEL‐19_5283144   19               5283144               32.8
  *Hint2*           CEL‐4_40541402   4                40541402              32.6
  *Agpat5*          rs3657963        8                16576750              32.1
  *Prss22*          rs3726555        17               15215815              31.5
  *Ccdc163*         rs3709486        4                109968331             30.7
  *Sys1*            rs3671849        2                163215888             30.4
  *Abhd1*           rs13469943       5                29486094              30.1
  *Tuft1*           rs13477261       3                92344335              28.0
  *Usp2*            rs4135590        9                43060131              28.0
  *H2*‐*Gs10*       rs3682923        17               34343989              27.7
  *Abhd1*           rs13469943       5                29486094              27.5
  *Zfp420*          rs4226520        7                18758740              27.5
  *H2‐T10*          rs6298471        17               35059374              26.9
  *Pdxdc1*          rs4163196        16               13143895              26.5
  *Fgr*             rs3663950        4                134187547             26.1
  *Scamp5*          rs13480208       9                55395056              25.7

eQTL indicates expression quantitative trait loci; LOD, logarithm of odds; BMM, bone marrow macrophage.

###### 

Top 25 *trans*‐eQTLs by LOD Score in BMMs

  Gene Symbol   QTL Chromosome   QTL Marker Position   QTL Marker       LOD    Probe Chromosome   Probe Location
  ------------- ---------------- --------------------- ---------------- ------ ------------------ ----------------
  *Akr1e1*      4                141638718             rs3023025        28.6   13                 4592177
  *Mcee*        7                51544526              rs3714908        16.5   7                  71556822
  *Man2a2*      7                65348455              rs13479355       16.4   7                  87505769
  *Gdpd3*       7                111285662             rs6275579        16.1   7                  133914693
  *Pde2a*       7                87305015              rs13479427       15.1   7                  108661076
  *Alg8*        7                80158909              rs4226783        14.7   7                  104540400
  *Gstp2*       1                188355284             rs3667164        14.2   19                 4041930
  *Man2a2*      7                66776784              rs13479358       13.0   7                  87505788
  *Dgcr6*       17               34343989              rs3682923        12.4   16                 18070266
  *Crym*        7                104533846             rs13479477       11.7   7                  127330117
  *Iqgap1*      7                65348455              rs13479355       10.8   7                  87857712
  *Stab 2*      13               63888326              rs4229817        10.7   10                 86304140
  *Heatr5a*     12               29204179              rs6223000        10.5   12                 52977981
  *Mlycd*       13               70810674              rs13481880       9.8    8                  121934766
  *Arap1*       7                77850273              CEL‐7_77850273   9.0    7                  108560953
  *Ifitm6*      7                126965988             rs3663988        9.0    7                  148201750
  *Fam168a*     7                77850273              CEL‐7_77850273   8.3    7                  107987317
  *Ints3*       3                60037290              rs13477138       7.7    3                  90195467
  *Plscr4*      9                63239299              gnf09.057.223    7.5    9                  92387070
  *Snrpn*       7                33835314              rs8260975        7.3    7                  67128021
  *Fam125b*     2                10929543              rs6240512        6.9    2                  33585812
  *Unc45a*      7                66776784              rs13479358       6.9    7                  87470214
  *Capn10*      17               45506664              rs6409750        6.6    1                  94844286
  *Nasp*        4                91308682              rs6271003        6.6    4                  116273846

eQTL indicates expression quantitative trait loci; LOD, logarithm of odds; BMM, bone marrow macrophage.

Lusis has proposed that mouse strain effects on EC function may underlie some strain effects on atherosclerosis.^[@b24]^ We successfully cultured primary aortic ECs from 48 male F~2~ mice used in the atherosclerosis study and assayed global gene expression by microarray. As expected, these cells expressed high levels of canonical EC transcripts encoding the proteins Tie2, the Vegf receptors, and von Willebrand factor, all of which were lowly expressed in BMMs. We applied the same FDR thresholds as in the macrophage analysis to identify EC *cis*‐ and *trans*‐eQTLs. At the 5% FDR threshold, corresponding to an LOD score of 2.47, we identified 440 *cis*‐eQTLs (Table S4 and top 25 in [Table 6](#tbl06){ref-type="table"}). For *trans*‐eQTLs, the 30% and 5% FDR thresholds corresponded to LOD scores of 2.70 and 3.92, with 4894 and 365 *trans*‐eQTLs identified, respectively (Table S5 and top 25 in [Table 7](#tbl07){ref-type="table"}).

###### 

Top 25 *cis*‐eQTLs by LOD Score in ECs

  Gene Symbol       QTL Chromosome   QTL Marker Position   QTL Marker        LOD
  ----------------- ---------------- --------------------- ----------------- ------
  *Thumpd1*         7                107424656             rs3709679         31.7
  *Mod1*            9                90513305              gnf09.087.298     29.2
  *Mff*             1                85865441              rs3723062         28.0
  *Paip1*           13               115056838             rs13482035        27.5
  *Ercc5*           1                44668113              CEL‐1_44668113    24.3
  *Lrrc57*          2                117074373             rs13476723        24.1
  *G430022H21Rik*   3                122002332             rs3659836         23.1
  *Aqr*             2                111095530             rs13476698        22.2
  *Atpbd*3          7                33574760              rs8255275         21.1
  *Abhd1*           5                29486094              rs13469943        18.9
  *Scoc*            8                82188194              rs13479863        17.1
  *Zfp277*          12               34954150              rs13481406        16.7
  *Grwd1*           7                33574760              rs8255275         16.2
  *Ugt1a6a*         1                87104170              UT_1\_89.100476   16.0
  *2610019P18Rik*   5                135836567             rs4225536         15.0
  *Rnf41*           10               122911418             rs13480803        15.0
  *Slc25a3*         10               93288075              rs13480712        14.9
  *Pdxdc1*          16               12215630              rs4162800         14.8
  *4930455C21Rik*   16               30855920              rs4168640         14.6
  *Il3ra*           14               7401248               rs3150398         14.6
  *Tpmt*            13               46624183              rs6411274         14.5
  *Arid4b*          13               12961456              rs13481697        14.2
  *Pdxdc1*          16               12215630              rs4162800         14.0
  *BC031748*        X                129847872             rs13484031        13.0

eQTL indicates expression quantitative trait loci; LOD, logarithm of odds; EC, endothelial cells.

###### 

Top 25 *trans*‐eQTLs by LOD Score in ECs

  Gene Symbol   QTL Marker      QTL Chromosome   QTL Marker Position   LOD    Probe Chromosome   Probe Location
  ------------- --------------- ---------------- --------------------- ------ ------------------ ----------------
  *Tob2*        rs13480854      11               7518795               7.24   15                 81679613
  *Adi1*        rs6344105       12               63022076              6.90   12                 29366235
  *Mrgprg*      rs13482407      14               114388484             6.46   7                  150950410
  *Rb1*         rs3663355       4                47358427              6.39   14                 73595412
  *P2ry6*       rs3707067       7                85992410              6.20   7                  108086188
  *Slc10a7*     rs13477617      4                27105003              5.99   8                  81230781
  *Trp53bp1*    rs13482418      15               3498960               5.94   2                  121025364
  *Mgst3*       rs6279930       1                137268795             5.92   1                  169303924
  *Fam168a*     rs13479324      7                57878499              5.89   7                  107987317
  *Eml1*        rs6393948       11               103272243             5.84   12                 109726577
  *Mrvi1*       rs13476928      2                174162530             5.82   7                  118012039
  *Tprn*        rs3669563       9                117891342             5.78   2                  25125227
  *Cdk2ap2*     rs6290836       14               9149500               5.71   19                 4098608
  *Spcs3*       gnf18.051.412   18               53592447              5.64   8                  55606073
  *Trap1*       rs3699561       1                130962369             5.54   16                 4040058
  *Eral1*       gnf04.123.367   4                126400415             5.50   11                 77887218
  *BC013529*    rs13477617      4                27105003              5.47   10                 7487771
  *Tcf20*       rs13483085      17               66984514              5.43   15                 82640181
  *Prpsap2*     rs13482673      15               82560799              5.42   11                 61543254
  *Rin3*        rs3721056       9                71328971              5.38   12                 103628978
  *Dhcr24*      rs3664408       2                161443571             5.37   4                  106259325
  *Nxt1*        rs3663950       4                134187547             5.36   2                  148501307
  *Rtn2*        rs13476928      2                174162530             5.34   7                  19881245
  *Mlst8*       rs13482035      13               115056838             5.33   17                 24610627

eQTL indicates expression quantitative trait loci; LOD, logarithm of odds; EC, endothelial cells.

To evaluate cross‐tissue eQTLs, we counted the number of *cis*‐eQTLs (5% FDR) and *trans*‐eQTLs (30% FDR) that were found in both macrophages and ECs. We identified 156 *cis*‐eQTLs (Table S6) common in both tissues, although our power was limited by the relatively small number of EC samples. We identified 12 cross‐tissue *cis*‐eQTLs that were located in the 3 replicated Ath QTLs in chromosomes 2, 15, and 17 ([Table 8](#tbl08){ref-type="table"}). An example of a cross‐tissue *cis*‐eQTL within an Ath QTL interval is *Sys1*, coding for the Golgi‐localized integral membrane protein homolog ([Figure 2](#fig02){ref-type="fig"}). In contrast to the 156 cross‐tissue *cis*‐eQTLs, there were only 18 cross‐tissue *trans*‐eQTLs at the 30% FDR threshold that overlapped the 2 tissues ([Table 9](#tbl09){ref-type="table"}). A replicated *trans*‐eQTL is defined one in which the *trans*‐eQTL markers map within 10 Mb of each other. On inspection, it appears that 3 of these cross‐tissue *trans*‐eQTLs on chromosome 7 may in fact be *cis*‐eQTLs, because the positions of the gene and the markers were on the chromosome 7 and only slightly greater that the 20‐Mb cutoff used to classify *cis‐*eQTLs. The low number of cross‐tissue *trans*‐eQTLs has been noted in previous studies.^[@b25]^ One of these cross‐tissue *trans*‐eQTLs mapped to the *Ath22* interval on chromosome 15, which was associated with the expression of the *Klf2* transcription factor on chromosome 8.

###### 

*cis*‐eQTLs That Are Found in Both ECs and BMMs at \<5% FDR That Also Reside Within the *AthQTLs*

  Probe_ID       Gene Symbols   QTL Chromosome   BMM eQTL Position   EC eQTL Position   BMM LOD   EC LOD
  -------------- -------------- ---------------- ------------------- ------------------ --------- --------
  ILMN_2674425   *Sys1*         2                163215888           163215888          30.45     10.91
  ILMN_1216029   *Cstf1*        2                174162530           174162530          3.87      3.67
  ILMN_2869312   *Fbxo4*        15               5744460             4222769            7.06      10.81
  ILMN_3123120   *Rnps1*        17               24100880            15215815           55.90     11.24
  ILMN_2601877   *Brd4*         17               34343989            34343989           2.97      4.60
  ILMN_2810539   *H2‐Gs10*      17               34343989            39772541           27.72     9.78
  ILMN_2691360   *Mrps10*       17               39772541            43897393           6.98      3.99
  ILMN_1256171   *Tmem63b*      17               43897393            43897393           16.68     8.49
  ILMN_2734045   *Mrpl14*       17               45506664            35059374           20.28     5.97
  ILMN_2804487   *Aif1*         17               45506664            39772541           2.62      3.49
  ILMN_2761876   *Fez2*         17               62066360            72668814           3.69      3.25
  ILMN_3090123   *Dync2li1*     17               82051202            87503632           22.79     6.35

eQTL indicates expression quantitative trait loci; EC, endothelial cells; BMM, bone marrow macrophage; FDR, false discovery rate; LOD, logarithm of odds.

###### 

*trans*‐eQTLs That Are Found in Both ECs and BMMs at \<30% FDR

  Probe_ID       Gene Symbols      QTL Chromosome   BMM eQTL Position   EC eQTL Position   BMM LOD   EC LOD   Probe Chromosome   Probe Position
  -------------- ----------------- ---------------- ------------------- ------------------ --------- -------- ------------------ ----------------
  ILMN_2759167   *Gtpbp5*          1                152747565           160294867          4.65      2.98     2                  179820490
  ILMN_2629375   *1110038F14Rik*   3                41838640            41838640           3.32      4.03     15                 76780014
  ILMN_2740285   *Fancl*           3                126894715           132189425          2.85      2.86     11                 26371341
  ILMN_2602837   *Akr1e1*          4                141638718           134187547          28.63     2.82     13                 4592177
  ILMN_1245307   *Fbln2*           5                39608047            39608047           3.04      2.79     6                  91221963
  ILMN_2685329   *Hspg2*           5                39608047            39608047           2.87      2.88     4                  137126406
  ILMN_2622057   *Tsen2*           5                117374791           111603432          3.16      4.78     6                  115527976
  ILMN_2791578   *Gspt1*           5                131766121           135836567          3.14      2.96     16                 11220678
  ILMN_1255175   *Unc45a*          7                66776784            65348455           6.09      3.31     7                  87470402
  ILMN_2893879   *Gdpd3*           7                111285662           112152410          16.13     5.25     7                  133914693
  ILMN_2689056   *Cd2bp2*          7                112152410           112152410          6.11      5.08     7                  134335721
  ILMN_2751354   *Pde4dip*         8                84344531            86397354           4.17      3.17     3                  97542917
  ILMN_2604029   *Klf2*            15               34383985            41359817           3.17      3.10     8                  74844875
  ILMN_1256434   *Pigk*            15               72483350            72483350           3.08      3.85     3                  152448803
  ILMN_2836924   *Wdr45*           15               95679367            92664963           2.97      2.74     20                 7305117
  ILMN_3114998   *Zfp658*          15               95679367            92664963           3.44      3.70     7                  50830408
  ILMN_2672778   *Abhd1*           17               66984514            69670995           3.11      3.18     5                  31255322
  ILMN_3038459   *Morf4l1*         19               21112530            29540192           2.86      2.76     9                  89998557

eQTL indicates expression quantitative trait loci; LOD, logarithm of odds; EC, endothelial cell; BMM, bone marrow macrophage; FDR, false discovery rate.

![Example of a replicated *cis*‐eQTL between tissues (A and C) and between studies (A and B) of *Sys1*, an integral Golgi‐associated membrane protein. Means±SEM are shown adjacent to the individual values. *P* and *R*^2^ values were obtained by linear regression with sex as an additive covariate. eQTL indicates expression quantitative trait loci; BMM, bone marrow macrophage; EC, endothelial cell.](jah3-2-e005421-g2){#fig02}

Macrophage eQTL Replication Between Different Crosses and Different Platforms
-----------------------------------------------------------------------------

A macrophage eQTL study was performed in the previous AKR×DBA/2 F~2~ intercross; however, different genetic markers and different expression array platforms were used. To examine replication of macrophage eQTLs between the current and previous study, we reanalyzed the prior data by imputing to the currently used 599 strain‐specific SNPs and mapping the Affymetrix gene expression probes to the currently used Illumina probes. After filtering out probes not mapped to the Illumina platform or those that were excluded in our new cross, only 5678 probes remained for analysis. We then performed the eQTL analysis of the prior dataset using sex as an additive covariate and obtained *cis‐* and *trans‐*eQTLs at the same FDRs as described earlier (summary statistics in [Table 10](#tbl10){ref-type="table"}). Of the 738 and 482 *cis*‐eQTLs identified in the prior and new crosses, respectively, 265 were replicated, representing 36% and 55% of the input *cis*‐eQTLs in the old and new cross, respectively ([Figure 3](#fig03){ref-type="fig"}, Table S7). The *cis*‐eQTL replication percentage range (36% to 55%) in our study is somewhat lower than that of previously published replication study by van Nas et al that found a *cis*‐eQTL replication rate of ≈50% to 60%.^[@b25]^ However, van Nas et al used the same platform and genotyping markers across their 2 studies, whereas we used separate platforms. In addition, van Nas et al probably overestimated the replication rate, because they did not remove probes containing strain polymorphic SNPs as we did in our study. We demonstrated that inclusion of the strain‐polymorphic probes leads to strong false‐positive eQTLs. *Sys1* not only had a cross‐tissue *cis*‐eQTL, but it is also an example of a cross‐study replicated *cis*‐eQTL in BMMs ([Figure 2](#fig02){ref-type="fig"}). The SNP rs3671849, within the *Ath28* locus, displayed a strong additive effect on the expression of *Sys1*, with the DBA/2 allele expressed higher. This marker was associated with 51% and 42% of the variation in BMM *Sys1* gene expression in the new and prior crosses, respectively, and 63% of the variation in EC *Sys1* gene expression.

###### 

Summary Statistics and Replication of Bone Marrow Macrophage *cis*‐ and *trans*‐eQTLs for the Prior and New Crosses Using the Restricted Set of Common Probes

                                                                                  *cis‐*eQTLs   *trans*‐eQTLs
  ------------------------------------------------------------------------------- ------------- ---------------
  No. of eQTLs (5% FDR) prior cross                                               738           281
  No. of eQTLs (5% FDR) new cross                                                 482           274
  No. of eQTLs common between old and new (5%)                                    265           5
  No. of eQTLs common between old and new (30%)                                   ND            23
  No. of eQTLs in combined analysis (5% FDR)[\*](#tf10-1){ref-type="table-fn"}    783           703
  No. of eQTLs in combined analysis (30% FDR)[\*](#tf10-1){ref-type="table-fn"}   ND            3158

eQTL indicates expression quantitative trait loci; FDR, false discovery rate; ND, not determined.

Combined sex eQTL analysis in both crosses using sex as an additive covariate.

![Venn diagram of the overlap between the *cis*‐eQTL in the new cross and the old cross. Transcripts were limited to only the transcripts that were called present in both and had corresponding probe between the platforms. eQTL indicates expression quantitative trait loci.](jah3-2-e005421-g3){#fig03}

There were only 5 *trans*‐eQTLs that replicated between the 2 crosses, or 0.9% and 0.6% of the old cross and new cross *trans*‐eQTLs, respectively, at a 5% FDR LOD score cutoff ([Table 11](#tbl11){ref-type="table"}). The LOD plots and allele effects on gene expression for the *Lamb2* gene, which had a replicated *trans*‐eQTL, is shown in [Figure 4](#fig04){ref-type="fig"}. Relaxing the FDR to 30% in both crosses resulted in 23 *trans*‐eQTLs that replicated between the studies, or 6% and 4% of the old cross and new cross *trans*‐eQTLs, respectively. This is lower than the ≈19% *trans*‐eQTL replication rate observed by van Nas et al; however, the same caveats apply to our analysis concerning our use of 2 expression array and SNP platforms.^[@b25]^

###### 

Replicated *trans*‐eQTL Between Crosses at the 5% FDR Level

  Prior Probe ID   New Probe ID   QTL Chromosome   Prior QTL Marker Position, Mb   New QTL Marker Position, Mb   Prior LOD Score   New LOD Score   Gene Symbol   Probe Chromosome   Probe Position, Mb
  ---------------- -------------- ---------------- ------------------------------- ----------------------------- ----------------- --------------- ------------- ------------------ --------------------
  1416513_at       ILMN_2699488   1                11.3                            4.5                           5.0               6.4             *Lamb2*       9                  108.4
  1419423_at       ILMN_2737368   13               74.5                            63.9                          6.3               10.7            *Stab 2*      10                 86.3
  1437470_at       ILMN_2780759   1                169.2                           188.4                         7.1               4.1             *Pknox1*      17                 31.7
  1448609_at       ILMN_2493175   1                8.1                             13.0                          13.9              5.1             *Tst*         15                 78.2
  1451343_at       ILMN_1240149   8                44.5                            43.9                          5.8               4.1             *Vps36*       8                  23.4

eQTL indicates expression quantitative trait loci; LOD, logarithm of odds; FDR, false discovery rate.

![An example of a replicating *trans*‐eQTL on chromosome 4 for the *Lamb2* gene residing on chromosome 9. eQTL indicates expression quantitative trait loci; LOD, logarithm of odds.](jah3-2-e005421-g4){#fig04}

As an alternative to examining replication of eQTLs, we combined the data from both F~2~ cohorts and performed a combined analysis of *cis‐* and *trans*‐macrophage eQTLs using sex and cross as additive covariates. The combined method has more power to identify eQTLs than the replication method because it uses a larger sample size and thus is not penalized by a near‐miss false‐negative result in 1 of the 2 crosses. In the combined analysis, there were 783 *cis*‐eQTLs at a 5% FDR threshold (Tables [10](#tbl10){ref-type="table"} and S8). An example of a significant *cis*‐eQTL found in the combined analysis, but not in the replicated analysis, is an eQTL for *Wdr70*, a WD40 repeat adapter protein. In the combined analysis, there were 160 *cis*‐eQTLs that were found that were not found in either analysis. Furthermore, there were 703 and 3158 *trans*‐eQTLs at the 5% and 30% FDR thresholds in the combined analysis, respectively (Tables [10](#tbl10){ref-type="table"} and S9).

We systematically searched for replicated eQTLs within the Ath QTL regions to identify potential atherosclerosis modifier candidate genes. In total, there were 14 genes that met this criterion, and for each we determined the correlation of macrophage gene expression and lesion area within the F~2~ mice of the prior and current crosses. Twelve of these correlations had conserved directions in the 2 crosses ([Table 12](#tbl12){ref-type="table"}). At the *Ath28* locus on chromosome 2, we identified 2 replicated macrophage *cis*‐eQTLs, of which *Sys1* may have a connection to cholesterol ester metabolism. *Sys1*, whose expression was positively associated with lesion area, is a Golgi‐localized integral membrane protein that is essential for the targeting for several proteins to the Golgi complex and membrane vesicles^[@b26]^ including the small GTPases *Arl3p* and *Arfrp1*. Deletion of *Arfrp1* results in loss of lipid droplet formation in adipocytes^[@b27]^; lipid droplets in macrophages store cholesterol esters and thus may play an important role in modifying atherosclerosis. At the *Ath26* locus on chromosome 17, there were 9 replicated eQTLs with a shared direction of lesion area correlation, 2 of which have some prior link to atherosclerosis. *Prss22* is a serine protease that converts prourokinase‐type plasminogen activator into its enzymatically active form, abbreviated as uPA.^[@b28]^ We found that *Prss22* expression was inversely correlated with atherosclerosis; thus, we would predict that uPA activity may also be inversely correlated with atherosclerosis. However, this is not the case, as previous studies have shown that macrophage expression of uPA is positively associated with atherosclerosis in apoE‐deficient mice.^[@b29]--[@b30]^ *Ltb*, encoding lymphotoxin‐β (a member of the tumor necrosis factor gene family), resides in the *Ath26* locus, and its expression was positively correlated with lesion area. Lymphotoxin‐β receptor signaling in the arterial media beneath atherosclerotic plauques has been found to promote tertiary lymphoid organogenesis.^[@b31]^ In addition, circulating levels of lymphotoxin‐β receptor in humans were positively associated with coronary artery calcium scores.^[@b32]^ However, it is difficult to interpret whether these findings are relevant to our observed correlation of macrophage *Ltb* expression and lesion area. None of the other replicated eQTLs at the Ath loci had obvious known connections to pathways implicated in atherosclerosis.

###### 

Replicated *cis*‐eQTL Within Replicated Ath QTL Intervals That Have Replicated Direction of Expression--Lesion Correlation

  Illumina Probe ID   Affymetrix Probe ID   Gene Symbol   QTL Chromosome   Expression--Lesion Correlation New Cross[\*](#tf12-1){ref-type="table-fn"}   Expression--Lesion Correlation Old Cross[\*](#tf12-1){ref-type="table-fn"}
  ------------------- --------------------- ------------- ---------------- ---------------------------------------------------------------------------- ----------------------------------------------------------------------------
  ILMN_2674425        1450057_at            *Sys1*        2                0.06                                                                         0.18
  ILMN_1216029        1448597_at            *Cstf1*       2                −0.16                                                                        −0.13
  ILMN_2710121        1416441_at            *Pgcp*        15               −0.19                                                                        −0.12
  ILMN_2688287        1420352_at            *Prss22*      17               −0.04                                                                        −0.18
  ILMN_2615207        1418321_at            *Eci1*        17               −0.29                                                                        −0.15
  ILMN_1219908        1418344_at            *Tmem8*       17               0.11                                                                         0.18
  ILMN_1218891        1419547_at            *Fahd1*       17               −0.06                                                                        −0.13
  ILMN_2667889        1417173_at            *Atf6b*       17               0.02                                                                         0.13
  ILMN_1241923        1449537_at            *Msh5*        17               −0.18                                                                        −0.26
  ILMN_2726308        1449021_at            *Rpp21*       17               −0.26                                                                        −0.10
  ILMN_1258283        1419135_at            *Ltb*         17               0.16                                                                         0.16
  ILMN_2761876        1434348_at            *Fez2*        17               −0.08                                                                        −0.07

eQTL indicates expression quantitative trait loci; Ath QTL, atherosclerosis quantitative trait loci.

Pearson\'s correlation *R* value.

Conclusions
===========

We found that phenotypic QTLs for the complex trait of atherosclerosis were partially reproducible. Of the 6 Ath QTLs indentified in the prior cross, the 2 significant QTLs replicated, as did 1 of 4 suggestive QTLs in a combined analysis with the new cross. In the new and smaller cross, all 3 of the suggestive Ath QTLs were found in the prior cross. Based on these results, it may be prudent to replicate phenotypic QTLs before embarking on extensive gene discovery and fine mapping studies.

We also report here than many *cis*‐eQTLs can be replicated in independent crosses even when the genotyping and gene expression platforms used differed between the studies. This is not unexpected because the *cis*‐eQTLs are direct and often have very strong effects on gene expression. However, we found a lower rate of *trans*‐eQTL replication compared with another replication study.^[@b25],[@b33]^ Our conclusion is that many *trans*‐eQTLs identified in mouse studies may be false positives, or very sensitive to environmental effects, making replication less likely.
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[^1]: Accompanying Figure S1 and Tables S1--S9 are available at <http://jaha.ahajournals.org/content/2/1/e005421.full>
